कृपया अन्य खोज का प्रयास करें
HitGen Inc. operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally. Its technology platform includes DNA-encoded library technology; fragment-based drug discovery and structure-based drug design technologies; emerging technology platforms for synthetic therapeutic oligonucleotide technology; and targeted protein degradation technology. The company’s product pipeline includes HG146, a selective HDAC inhibitor for multiple myeloma and solid tumor; HG030, a second generation NTRK/ROS1 inhibitor tablet for solid tumor; and HG 381, an immune-oncology agonist for cancer, as well as HGT01 and HGT02, an tumor immunology for cancer. In addition, it offers HGT03, a protein degrader, and HGT04, a transcriptomics for cancer; and HGT05, a kinase inhibitor for liver cancer, as well as HGP0508, a small molecule for anti-inflammatory therapeutics for inflammation, and HGC245, a kinase inhibitor for glaucoma. The company’s nucleic acid drug pipeline includes HGP2142, an TGF-ß1 specific siRNA drug for liver cancer; HGN001, a nucleic acid drug for specific mutation of cancer target; and HGN002 for Solid tumor. Further, it offers target validation, hit identification, hit-to-lead optimization, lead optimization, preclinical studies and IND, clinical development, and integrated drug discovery services. Additionally, the company focus on oncology and immuno-oncology, inflammatory and autoimmune diseases, ophthalmology, infectious, metabolic, and cardiovascular diseases. HitGen Inc. was founded in 2012 and is based in Chengdu, China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Li Jin | 59 | - | Chairman & GM |
Yanfei Zhu | 47 | - | Chairman of the Supervisory Board |
Haizong Yu | 58 | - | Independent Director |
Jianguo Li | 61 | - | Director |
Yu Quan Wei | 63 | - | Independent Director |
Lin Wang | 54 | - | Director |
Li Suibo | 63 | 2022 | Director |
Yunpei Guo | 77 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है